Artwork

Indhold leveret af BBC and BBC Radio 4. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af BBC and BBC Radio 4 eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Health special 1: Advances in cancer research and treatment

36:27
 
Del
 

Manage episode 428275403 series 1301271
Indhold leveret af BBC and BBC Radio 4. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af BBC and BBC Radio 4 eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Half the UK population will get cancer during their lifetime - and rates are rising. Each year, around 385,000 people in the UK are diagnosed and around 167,00 lives are lost to the disease. But scientists are developing new therapies, including personalised vaccines and targeted drugs, that attack cancer cells directly and more effectively. It's hoped this pioneering work could lead to better survival rates. David Aaronovitch and guests discuss promising developments in cancer care - to find out how significant they might be.

Guests: Professor Charles Swanton, chief clinician at Cancer Research UK and deputy clinical director at the Francis Crick Institute; Dr Olivia Rossanese, Director of the Centre for Cancer Drug Discovery at the Institute of Cancer Research; Christian Ottensmeier, Professor of Immuno-Oncology at the University of Liverpool; Professor Alan Melcher, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust

Presenter: David Aaronovitch Producers: Rosamund Jones and Sally Abrahams Sound engineers: Rod Farquhar and Neil Churchill Editor: Richard Vadon

  continue reading

322 episoder

Artwork
iconDel
 
Manage episode 428275403 series 1301271
Indhold leveret af BBC and BBC Radio 4. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af BBC and BBC Radio 4 eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Half the UK population will get cancer during their lifetime - and rates are rising. Each year, around 385,000 people in the UK are diagnosed and around 167,00 lives are lost to the disease. But scientists are developing new therapies, including personalised vaccines and targeted drugs, that attack cancer cells directly and more effectively. It's hoped this pioneering work could lead to better survival rates. David Aaronovitch and guests discuss promising developments in cancer care - to find out how significant they might be.

Guests: Professor Charles Swanton, chief clinician at Cancer Research UK and deputy clinical director at the Francis Crick Institute; Dr Olivia Rossanese, Director of the Centre for Cancer Drug Discovery at the Institute of Cancer Research; Christian Ottensmeier, Professor of Immuno-Oncology at the University of Liverpool; Professor Alan Melcher, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust

Presenter: David Aaronovitch Producers: Rosamund Jones and Sally Abrahams Sound engineers: Rod Farquhar and Neil Churchill Editor: Richard Vadon

  continue reading

322 episoder

Alle afleveringen

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning